ArticleNature communications2023
Rewired m
Open access · goldFull text read
In one paragraph
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Mapping the Cerebral Organoid Landscape: A Systematic Review of Preclinical 3D Models in Neuroscience.Advanced healthcare materials · 2026Pooled it
- The YTHDF proteins modulate Alzheimer's disease-associated brain gene signatures.Molecular neurodegeneration · 2026Article
- RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting.Functional & integrative genomics · 2026Review
- An artificial intelligence optimized hepatic differentiation unveils NR5A2 and AP-1 transcriptional regulation in hepatic maturation.The Journal of biological chemistry · 2026Article
- Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants.International journal of molecular sciences · 2026Article
- Human iPSC-derived and conventional cancer models in precision oncology: advancing patient-specific therapies from bench to bedside.Journal of experimental & clinical cancer research : CR · 2026Review
- Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, mJournal of advanced research · 2025Review
- Rewired m6A of promoter antisense RNAs in Alzheimer's disease regulates neuronal genes in 3D nucleome.Nature communications · 2025Article
- Review
- Decoding cancer etiology with cellular reprogramming.Current opinion in genetics & development · 2025Review
- Structural basis of the human transcriptional Mediator regulated by its dissociable kinase module.Molecular cell · 2024Article
- Decoding the molecular symphony: interactions between the mNAR cancer · 2024Review
- Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53.Biology · 2024Review
- YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.Experimental and therapeutic medicine · 2024Article
- SPOCK2 modulates neuropathic pain by interacting with MT1-MMP to regulate astrocytic MMP-2 activation in rats with chronic constriction injury.Journal of neuroinflammation · 2024Article
- Cancer-associated MDM2 W329G mutant attenuates ribosomal stress-mediated p53 responses to promote cell survival and glycolysis.American journal of cancer research · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors at 13 institutions in 4 countries.
An Xu *Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.ORCID 0000-0003-1776-7972
Mo Liu *Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Mo-Fan HuangDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.ORCID 0000-0002-2209-1236
Yang ZhangCollege of Science, Harbin Institute of Technology (Shenzhen), Shenzhen, Guangdong, 518055, China.ORCID 0000-0002-3503-5161
Ruifeng HuCenter for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Julian A GingoldDepartment of Obstetrics & Gynecology and Women's Health, Einstein/Montefiore Medical Center, Bronx, NY, 10461, USA.ORCID 0000-0002-0354-5933
Ying LiuDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Dandan ZhuDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.ORCID 0000-0003-4609-1238
Chian-Shiu ChienDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, 112, Taiwan.ORCID 0000-0001-9666-1273
Wei-Chen WangInstitute of Molecular Biology, National Chung Hsing University, Taichung, 40227, Taiwan.
Zian LiaoVerna & Marrs McLean Department of Biochemistry & Molecular Biology and Therapeutic Innovation Center, Baylor College of Medicine, Houston, TX, 77030, USA.
Fei YuanVerna & Marrs McLean Department of Biochemistry & Molecular Biology and Therapeutic Innovation Center, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID 0000-0002-1007-2863
Chih-Wei HsuDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, 77030, USA.
Jian TuDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Yao YuDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID 0000-0002-2727-1746
Taylor RosenDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.ORCID 0000-0002-4254-8109
Feng XiongDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Peilin JiaCenter for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
Yi-Ping YangDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
Danielle A BazerDepartment of Neurology, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA.
Ya-Wen ChenDepartment of Otolaryngology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.ORCID 0000-0003-2382-8444
Wenbo LiThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.ORCID 0000-0002-9042-5664
Chad D HuffThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.
Jay-Jiguang ZhuDepartment of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.ORCID 0000-0003-4635-0914
Francesca AguiloWallenberg Centre for Molecular Medicine (WCMM), Umea University, SE-901 85, Umea, Sweden.ORCID 0000-0002-2374-2045
Shih-Hwa ChiouDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, 112, Taiwan.
Nathan C BolesNeural Stem Cell Institute, Rensselaer, NY, 12144, USA.ORCID 0000-0002-9253-9411
Chien-Chen LaiInstitute of Molecular Biology, National Chung Hsing University, Taichung, 40227, Taiwan.ORCID 0000-0002-7133-8266
Mien-Chie HungGraduate Institute of Biomedical Sciences and Center for Molecular Medicine, and Office of the President, China Medical University, Taichung, 404, Taiwan.ORCID 0000-0003-4317-4740
Zhongming ZhaoThe University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.ORCID 0000-0002-3477-0914
Eric L Van NostrandVerna & Marrs McLean Department of Biochemistry & Molecular Biology and Therapeutic Innovation Center, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID 0000-0002-5188-0082
Ruiying ZhaoDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. ruiying.zhao@uth.tmc.edu.
Dung-Fang LeeDepartment of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA. dung-fang.lee@uth.tmc.edu.ORCID 0000-0003-2387-597X
The University of Texas Health Science Center at Houston · USThe University of Texas MD Anderson Cancer Center · USBaylor College of Medicine · USNational Yang Ming Chiao Tung University · TWNational Chung Hsing University · TWAlbert Einstein College of Medicine · USAsia University · TWHarbin Institute of Technology · CNIcahn School of Medicine at Mount Sinai · USNeural Stem Cell Institute · USStony Brook School · USThe University of Texas Health Science Center · USUmeå University · SE
Funding
Transforming dbGaP genetic and genomic data to FAIR-ready by artificial intelligence and machine learning algorithmsR01LM012806 · NLM · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Zhongming Zhao · 2017 to 2026
$3.7MDissecting and Targeting RB1-Mutant OsteosarcomaR01CA246130 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LEE, DUNG-FANG · 2021 to 2025
$2.1MOrbitrap Elite High-Resolution Mass Spectrometer for Proteomics and MetabolomicsS10OD012304 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HAWKE, DAVID H · 2013 to 2013
$877kNCI NIH HHS R01 CA246130NIH HHS S10 OD012304NLM NIH HHS R01 LM012806
Abstract
N6-methyladenosine (m
Indexed as
GliomaLi-Fraumeni SyndromeCell Transformation, NeoplasticHumansProteoglycansTumor Suppressor Protein p53ProteoglycansSPOCK2 protein, humanTumor Suppressor Protein p53
Identifiers
What OpenQuestion holds
Textfull text, public
LicenceCC BY
reference markers read2
measurements read208
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.